Xiaowang Qu

2.1k total citations · 1 hit paper
35 papers, 1.0k citations indexed

About

Xiaowang Qu is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Xiaowang Qu has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 16 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Xiaowang Qu's work include SARS-CoV-2 and COVID-19 Research (11 papers), Hepatitis C virus research (10 papers) and Respiratory viral infections research (8 papers). Xiaowang Qu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Hepatitis C virus research (10 papers) and Respiratory viral infections research (8 papers). Xiaowang Qu collaborates with scholars based in China, United States and New Zealand. Xiaowang Qu's co-authors include Wenpei Liu, Weijin Huang, Jian Zhang, Youchun Wang, Qianqian Li, Bo Wen, Ziteng Liang, Li Zhang, Shuo Liu and Tao Li and has published in prestigious journals such as Journal of Virology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaowang Qu

34 papers receiving 996 citations

Hit Papers

The significant immune escape of pseudotyped SARS-CoV-2 v... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Xiaowang Qu
Bi-Hung Peng United States
James T. Earnest United States
Jingyou Yu United States
Kimberly Robins United States
Emma S. Winkler United States
Emanuela Pelosi United Kingdom
Bi-Hung Peng United States
Xiaowang Qu
Citations per year, relative to Xiaowang Qu Xiaowang Qu (= 1×) peers Bi-Hung Peng

Countries citing papers authored by Xiaowang Qu

Since Specialization
Citations

This map shows the geographic impact of Xiaowang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowang Qu more than expected).

Fields of papers citing papers by Xiaowang Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowang Qu. The network helps show where Xiaowang Qu may publish in the future.

Co-authorship network of co-authors of Xiaowang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowang Qu. A scholar is included among the top collaborators of Xiaowang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowang Qu. Xiaowang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qian, Yongchen Liu, Zhendong Pan, et al.. (2025). Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients. Antiviral Research. 235. 106092–106092. 5 indexed citations
2.
Lü, Rui, Rongzhang He, Jun Chen, et al.. (2024). Regulatory T and CXCR3+ Circulating Tfh Cells Concordantly Shape the Neutralizing Antibody Responses in Individuals Who Have Recovered from Mild COVID-19. The Journal of Infectious Diseases. 230(1). 28–37. 2 indexed citations
3.
Wang, You, Qian Wu, Rui Lü, et al.. (2024). SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination. Frontiers in Immunology. 15. 1355949–1355949. 3 indexed citations
4.
Chang, Fangfang, Qian Wu, Zhendong Pan, et al.. (2024). Engineered bispecific antibodies with enhanced breadth and potency against SARS-CoV-2 variants and SARS-related coronaviruses. Medical Microbiology and Immunology. 213(1). 24–24. 1 indexed citations
5.
Liu, Yongcheng, Jing Yang, Jun Chen, et al.. (2022). Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses. Frontiers in Immunology. 13. 1056272–1056272. 6 indexed citations
6.
Wu, Jiajing, Jianhui Nie, Li Zhang, et al.. (2022). The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain. Signal Transduction and Targeted Therapy. 7(1). 18–18. 13 indexed citations
7.
Zhang, Li, Qianqian Li, Ziteng Liang, et al.. (2021). The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerging Microbes & Infections. 11(1). 1–5. 248 indexed citations breakdown →
8.
Wu, Jiajing, Li Zhang, Yue Zhang, et al.. (2021). The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Frontiers in Immunology. 12. 687869–687869. 13 indexed citations
9.
Wang, Meiyu, Li Zhang, Qianqian Li, et al.. (2021). Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination. Emerging Microbes & Infections. 11(1). 18–29. 23 indexed citations
10.
Zhang, Jian, Wenpei Liu, Bo Wen, et al.. (2019). Circulating CXCR3+ Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients. Scientific Reports. 9(1). 10090–10090. 44 indexed citations
11.
Zhang, Jian, Wenpei Liu, Ting Xie, et al.. (2019). Elevated LAG-3 on CD4+ T cells negatively correlates with neutralizing antibody response during HCV infection. Immunology Letters. 212. 46–52. 9 indexed citations
12.
Wen, Bo, et al.. (2018). Altered regulatory cytokine profiles in cases of pediatric respiratory syncytial virus infection. Cytokine. 103. 57–62. 14 indexed citations
13.
Li, Haipeng, Yuanyuan Li, Bo Wen, et al.. (2017). Dengue virus and Japanese encephalitis virus infection of the central nervous system share similar profiles of cytokine accumulation in cerebrospinal fluid. Central European Journal of Immunology. 42(2). 218–222. 9 indexed citations
14.
Zhang, Jian, Bo Wen, Chan Liu, et al.. (2016). Respiratory syncytial virus subtype ON1/NA1/BA9 predominates in hospitalized children with lower respiratory tract infections. Journal of Medical Virology. 89(2). 213–221. 31 indexed citations
15.
Zhang, Jian, Bo Wen, Shan Luo, et al.. (2016). HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection. Scientific Reports. 6(1). 39409–39409. 18 indexed citations
16.
Pan, Xiao‐Ben, et al.. (2013). BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells. Antiviral Research. 98(1). 54–60. 34 indexed citations
17.
Ma, Dongling, Dong Jiang, Min Qing, et al.. (2009). Antiviral effect of interferon lambda against West Nile virus. Antiviral Research. 83(1). 53–60. 42 indexed citations
18.
Qu, Xiaowang, Wenpei Liu, Zhengyu Qi, et al.. (2007). Phospholipase A2-like activity of human bocavirus VP1 unique region. Biochemical and Biophysical Research Communications. 365(1). 158–163. 39 indexed citations
19.
Qu, Xiaowang. (2006). Human Bocavirus Infection among the Hospitalized Children with Acute Respiratory Tract Disease in China.
20.
Duan, Zhaojun, Canping Huang, & Xiaowang Qu. (2006). Phylogenetic and Sequence Analyses of the N and S Genes of Coronavirus HKU1,a Novel Human Coronavirus in Mainland China. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026